Cargando…
Emergency department targeted screening for hepatitis C does not improve linkage to care
BACKGROUND: Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease worldwide. New treatments for HCV revolutionized management and prompted the world health organization to set the goal of viral elimination by 2030. These developments strengthen the need for HCV screening in o...
Autores principales: | Houri, Inbal, Horowitz, Noya, Katchman, Helena, Weksler, Yael, Miller, Ofer, Deutsch, Liat, Shibolet, Oren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459203/ https://www.ncbi.nlm.nih.gov/pubmed/32921964 http://dx.doi.org/10.3748/wjg.v26.i32.4878 |
Ejemplares similares
-
Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trial
por: Deutsch, Liat, et al.
Publicado: (2020) -
Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency Virus
por: Bar, Nir, et al.
Publicado: (2022) -
Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2021) -
Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
por: Meringer, Hadar, et al.
Publicado: (2019) -
Reply to: “Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!”
por: Rabinowich, Liane, et al.
Publicado: (2022)